Assessing Cirrhosis Quality of Care While Accounting for Cost

Last updated: March 11, 2019
Sponsor: New York Presbyterian Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Hyponatremia

Scar Tissue

Hepatic Fibrosis

Treatment

N/A

Clinical Study ID

NCT03414398
1710018603
  • Ages 18-80
  • All Genders

Study Summary

The objective of this study is to determine what influences the patient and caregiver perception of care, and if this perception associates with the percentage of and what quality metrics are being met and outcomes. The investigators also plan to capture the cost of providing quality metrics and the cost of monitoring adherence to quality metrics.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • primary liver cirrhosis

  • receiving care at the study cite

  • no evidence of hepatic encephalopathy if the subject is providing consent

Exclusion

Exclusion Criteria:

  • no documentation of cirrhosis

  • unable to confirm diagnosis of cirrhosis by imaging or pathology

Study Design

Total Participants: 273
Study Start date:
December 26, 2017
Estimated Completion Date:
July 01, 2021

Study Description

This study will be conducted using mixed-methods. The qualitative part will consist of in person, 1:1, open ended in depth interviews using a standard interview guide with probes. The quantitative part will document subjects meeting or not meeting the quality metrics supported by strong evidence, clinical outcomes, and medical bills.

Connect with a study center

  • New York Presbyterian Hospital - Weill Cornell Medicine

    New York, New York 10021
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.